Dean’s Lecture to feature FDA commissioner Robert Califf, PhD

By Roman Petrowski, Office of Communications

Dr. Robert Califf - FDA Commissioner
Robert Califf, PhD

Robert Califf, PhD, commissioner of the U.S. Food and Drug Administration, will present the second edition of the 2022 Dean’s Lecture at McGovern Medical School, Oct. 11.

The lecture, “Evidence Generation and Dealing with Misinformation: Public Health Priorities of our Time,” will be held from 4-5 p.m. in MSB 3.001.

Califf was confirmed as the 25th Commissioner of Food and Drugs in early 2022. He also served in 2016 as the 22nd commissioner, and immediately prior to that as the FDA’s Deputy Commissioner for Medical Products and Tobacco.

Califf has spent a good portion of his career affiliated with Duke University, where he served as a professor of medicine and vice chancellor for clinical and translational research, director of the Duke Translational Medicine Institute, and founding director of the Duke Clinical Research Institute.

He has had a long and distinguished career as a physician, researcher, and leader in the field of science and medicine. He is a nationally recognized expert in cardiovascular medicine, health outcomes research, health care quality, and clinical research, and is a leader in the growing field of translational research, which is key to ensuring that advances in science translate into medical care.

Califf is a graduate of Duke University School of Medicine. He completed a residency in internal medicine at the University of California, San Francisco, and a fellowship in cardiology at Duke.

Established in 1983, the Dean’s Lecture promotes and encourages professional development and sparks collaborative interest. Sponsored by the Research Committee, each year eminent scientists across various scientific disciplines are invited to present their work.